Graham H Litchman
2PUBLICATIONS
1CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Sep 08, 2022
Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.Perry B Hooper, Aaron S Farberg, Alison L Fitzgerald
|May 07, 2020
Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma.Graham H Litchman, Alison L Fitzgerald, Sarah J Kurley
Pageof 1

